The BioPhase 8800 system is a multi-capillary electrophoresis system that enables biopharma scientists to run multiple samples in parallel, accelerating the development and execution of sensitive, high-throughput analytical methods. The increased throughput and reproducibility of the system minimizes bottlenecks in the drug development pipeline, helping shorten time to market.

• Take on multiple molecules and multiple applications in less time - all on a single platform
• Shorten time to market with high-throughput, eight-capillary analytics
• With user-friendly software and pre-packaged reagents, running applications on the the BioPhase 8800 system is quick and easy
• Easily handle new and more complex molecules and their analytical challenges
• Shorten the time from start-up to answers using eight channels combined with validated kits and simplified software
• With high-sensitivity UV and laser-induced fluorescence (LIF) detectors, the BioPhase 8800 system generates results you can trust

The BioPhase 8800 system facilitates parallel processing of eight samples simultaneously, while retaining the capability to deliver sensitive capillary electrophoresis sodium dodecyl sulfate (CE-SDS), ribonucleic acid (RNA), capillary isoelectric focusing (cIEF) and glycan characterization analysis, enabling uncompromised accuracy for large sample sets and faster time to answers.

Delivering consistent, comparable and compliant data at scale across the biologic development continuum, the BioPhase 8800 system provides high-throughput, high-sensitivity analysis for bioprocessing, analytical development and QA/QC, all in a single system.